Fig. 2

MiR-186 overexpression sensitized ovarian cancer cells to paclitaxel and cisplatin. a and b MiR-186 overexpression induced the sensitivity of ovarian cancer cells to paclitaxel and cisplatin compared with miR-C transfected cells. c and d Besides, miR-186 transfection also reduced cancer cell proliferation. Results are representative of three separate experiments. Data are expressed as the mean ± standard deviation. * P < 0.05